Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseases

Adv Biol Regul. 2017 Aug:65:77-88. doi: 10.1016/j.jbior.2017.05.005. Epub 2017 May 26.

Abstract

Natural products or nutraceuticals promote anti-aging, anti-cancer and other health-enhancing effects. A key target of the effects of natural products may be the regulation of the PI3K/PTEN/Akt/mTORC1/GSK-3 pathway. This review will focus on the effects of curcumin (CUR), berberine (BBR) and resveratrol (RES), on the PI3K/PTEN/Akt/mTORC1/GSK-3 pathway, with a special focus on GSK-3. These natural products may regulate the pathway by multiple mechanisms including: reactive oxygen species (ROS), cytokine receptors, mirco-RNAs (miRs) and many others. CUR is present the root of turmeric (Curcuma longa). CUR is used in the treatment of many disorders, especially in those involving inflammatory processes which may contribute to abnormal proliferation and promote cancer growth. BBR is also isolated from various plants (Berberis coptis and others) and is used in traditional medicine to treat multiple diseases/conditions including: diabetes, hyperlipidemia, cancer and bacterial infections. RES is present in red grapes, other fruits and berries such as blueberries and raspberries. RES may have some anti-diabetic and anti-cancer effects. Understanding the effects of these natural products on the PI3K/PTEN/Akt/mTORC1/GSK-3 pathway may enhance their usage as anti-proliferative agent which may be beneficial for many health problems.

Keywords: Berberine; Curcumin; Natural products; Resveratrol.

Publication types

  • Review

MeSH terms

  • Berberine / therapeutic use*
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / enzymology
  • Cardiovascular Diseases / genetics
  • Cardiovascular Diseases / pathology
  • Curcumin / therapeutic use*
  • Gene Expression Regulation / drug effects*
  • Glycogen Synthase Kinase 3 / genetics*
  • Glycogen Synthase Kinase 3 / metabolism
  • Humans
  • Inflammation
  • Mechanistic Target of Rapamycin Complex 1 / genetics
  • Mechanistic Target of Rapamycin Complex 1 / metabolism
  • Neoplasms / drug therapy
  • Neoplasms / enzymology
  • Neoplasms / genetics
  • Neoplasms / pathology
  • Neurodegenerative Diseases / drug therapy
  • Neurodegenerative Diseases / enzymology
  • Neurodegenerative Diseases / genetics
  • Neurodegenerative Diseases / pathology
  • Osteoarthritis / drug therapy
  • Osteoarthritis / enzymology
  • Osteoarthritis / genetics
  • Osteoarthritis / pathology
  • PTEN Phosphohydrolase / genetics
  • PTEN Phosphohydrolase / metabolism
  • Phosphatidylinositol 3-Kinases / genetics
  • Phosphatidylinositol 3-Kinases / metabolism
  • Protective Agents / therapeutic use*
  • Proto-Oncogene Proteins c-akt / genetics
  • Proto-Oncogene Proteins c-akt / metabolism
  • Resveratrol
  • Signal Transduction
  • Stilbenes / therapeutic use*

Substances

  • Protective Agents
  • Stilbenes
  • Berberine
  • Phosphatidylinositol 3-Kinases
  • Mechanistic Target of Rapamycin Complex 1
  • Proto-Oncogene Proteins c-akt
  • Glycogen Synthase Kinase 3
  • PTEN Phosphohydrolase
  • PTEN protein, human
  • Curcumin
  • Resveratrol